As Launch Date Nears, Is Ranbaxy Exploring Talks To Monetize Lipitor First-launch Opportunity With Generic Rivals?
This article was originally published in The Pink Sheet Daily
Executive Summary
Agreement with Impax on launch of generic tamsulosin could be one model for atorvastatin strategy.
You may also be interested in...
Watson Talks Up Prochieve And Global Expansion At Analyst Meeting
Watson Pharmaceutical Inc.'s recent analyst meeting provided a substantial window on a company that is in the midst of a multi-year transformation, with insights into its growth strategy through 2013, but also with some potentially important qualifiers.
Watson Talks Up Prochieve And Global Expansion At Analyst Meeting
Watson Pharmaceutical Inc.'s recent analyst meeting provided a substantial window on a company that is in the midst of a multi-year transformation, with insights into its growth strategy through 2013, but also with some potentially important qualifiers.
Ranbaxy May Be Hit With Significant Disgorgement Penalty For GMP Violations
MUMBAI - Ranbaxy's long-running encounter with U.S. FDA over American regulatory allegations of significant deficiencies at two Ranbaxy manufacturing sites - Paonta Sahib and Dewas - may be headed for a settlement in coming months, with the Indian generics flag-bearer paying out several million dollars in penalties